Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression

被引:82
作者
Cornils, Hauke [1 ]
Kohler, Reto S. [1 ]
Hergovich, Alexander [2 ]
Hemmings, Brian A. [1 ]
机构
[1] Friedrich Miescher Inst Biomed Res, Basel, Switzerland
[2] UCL, UCL Canc Inst, London, England
关键词
NDR/LATS kinase family; NDR1; NDR2; STK38; STK38L; MST kinases; MST3; HIPPO; p21; c-myc; MITOTIC EXIT-NETWORK; TUMOR-SUPPRESSOR LATS1; PHOSPHORYLATION; PROLIFERATION; APOPTOSIS; MECHANISM; YEAST; ACTS; DEGRADATION; ACTIVATION;
D O I
10.4161/cc.10.12.15826
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
The mammalian genome encodes 4 members of the NDR/LATS kinase family: NDR1 (STK38), NDR2 (STK38L), LATS1 and LATS2, which are highly conserved from yeast to man. Members of the NDR/LATS kinase family have been implicated in a variety of biological processes ranging from cell division and morphology to apoptosis and tumor suppression. In mammals LATS1/2 function as central parts of the HIPPO tumor suppressor pathway by restricting the activity of the YAP/TAZ proto-oncogenes. Recent evidence suggested that NDR1/2 are also part of an extended HIPPO tumor suppressor pathway. Apart from functions in apoptosis signaling and tumor suppression, NDR1/2 have been implicated in controlling centrosome duplication and mitotic chromosome alignment downstream of the HIPPO kinase homologs MST1 and MST2. Significantly, we also reported recently that NDR1/2 are controlling G(1)/S transition downstream of a third MST family member MST3. Intriguingly, this newly described MST3-NDR1/2 axis promotes G(1) progression by stabilizing c-myc and preventing p21 accumulation, indicating a potential pro-tumorigenic role for NDR kinases. Here we discuss these novel cell cycle functions of NDR kinases in a broader context and elaborate on possible explanations for the opposing functions of NDR kinases in normal and tumor biology.
引用
收藏
页码:1897 / 1904
页数:8
相关论文
共 74 条
[1]
p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]
Transcriptional regulation and transformation by MYC proteins [J].
Adhikary, S ;
Eilers, M .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (08) :635-645
[3]
Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model [J].
Adnane, J ;
Jackson, RJ ;
Nicosia, SV ;
Cantor, AB ;
Pledger, WJ ;
Sebti, SM .
ONCOGENE, 2000, 19 (47) :5338-5347
[4]
MYC in Oncogenesis and as a Target for Cancer Therapies [J].
Albihn, Ami ;
Johnsen, John Inge ;
Henriksson, Marie Arsenian .
ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 :163-224
[5]
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation [J].
Asada, M ;
Yamada, T ;
Ichijo, H ;
Delia, D ;
Miyazono, K ;
Fukumuro, K ;
Mizutani, S .
EMBO JOURNAL, 1999, 18 (05) :1223-1234
[6]
Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development [J].
Avruch, J. ;
Zhou, D. ;
Fitamant, J. ;
Bardeesy, N. .
BRITISH JOURNAL OF CANCER, 2011, 104 (01) :24-32
[7]
Men and sin: What's the difference? [J].
Bardin, AJ ;
Amon, A .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (11) :815-826
[8]
Bearss DJ, 2002, CANCER RES, V62, P2077
[9]
Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein [J].
Bichsel, SJ ;
Tamaskovic, R ;
Stegert, MR ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) :35228-35235
[10]
Human LATS1 is a mitotic exit network kinase [J].
Bothos, J ;
Tuttle, RL ;
Ottey, M ;
Luca, FC ;
Halazonetis, TD .
CANCER RESEARCH, 2005, 65 (15) :6568-6575